What role do cells, mediators, and bacteria play in HS pathophysiology? Catch up on key updates from EHSF 2024, with an expert interview featuring Dr Philippe Guillem (Clinique du Val d’Ouest, Ecully, France).
Dr Guillem discusses updates in pathophysiology, including involvement of fibroblasts and the interaction between bacteria and the immune system in HS. View transcript.
This content has been developed independently of the sponsor, UCB Biopharma SRL, which has had no editorial input into the content. EPG Health received funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.
